News stories about Transcat (NASDAQ:TRNS) have been trending somewhat positive recently, according to Accern. The research firm scores the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Transcat earned a news sentiment score of 0.09 on Accern’s scale. Accern also assigned news headlines about the scientific and technical instruments company an impact score of 46.2848947575206 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
These are some of the headlines that may have effected Accern’s scoring:
- Contrasting Transcat (TRNS) & Its Competitors (americanbankingnews.com)
- Contrasting Transcat (TRNS) & KEMET (KEM) (americanbankingnews.com)
- Financial Review: Transcat (TRNS) & Its Rivals (americanbankingnews.com)
- Transcat (TRNS) vs. Its Rivals Head-To-Head Survey (americanbankingnews.com)
- Reviewing Transcat (TRNS) & The Competition (americanbankingnews.com)
Shares of Transcat (NASDAQ TRNS) traded up $0.40 during trading hours on Wednesday, reaching $15.60. The company’s stock had a trading volume of 2,700 shares, compared to its average volume of 15,241. Transcat has a 52-week low of $11.30 and a 52-week high of $16.49. The company has a current ratio of 1.98, a quick ratio of 1.38 and a debt-to-equity ratio of 0.50. The firm has a market cap of $108.72, a PE ratio of 22.94, a PEG ratio of 2.71 and a beta of 0.40.
A number of equities analysts have recently issued reports on TRNS shares. Zacks Investment Research downgraded Transcat from a “hold” rating to a “sell” rating in a research note on Wednesday, December 20th. Singular Research started coverage on Transcat in a research note on Wednesday, November 15th. They set a “buy” rating and a $15.30 target price for the company. Finally, Roth Capital began coverage on Transcat in a research note on Friday, February 9th. They set a “buy” rating and a $20.00 target price for the company.
In other news, Director John T. Smith sold 2,000 shares of the firm’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $15.70, for a total transaction of $31,400.00. Following the sale, the director now owns 33,100 shares in the company, valued at $519,670. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 8.80% of the stock is owned by company insiders.
Transcat Company Profile
Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.